Green Cross Surges 17.16% Amid Cord Blood Theme Rally

On July 13, the cord blood theme showed strong performance, rising by 3.56% compared to the previous day. Among the related stocks, Green Cross (GC Pharma) is drawing attention as it surged by 17.16% from the previous day. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

[Graph] Major Stock Price Fluctuations in the Cord Blood Theme



According to provisional data compiled at 10:10 a.m., institutional investors have net sold 41,000 shares of Green Cross, indicating significant net selling activity by institutions.

[Table] Net Buying/Selling Volume by Foreign and Institutional Investors (Unit: 10,000 shares)



According to analysis by Thinkpool’s robo-algorithm RASSI, Green Cross received a quant financial score of 29.47 points, ranking second within the cord blood theme. Its stability and profitability scores are higher than the average of other stocks in the theme. This indicates that, in terms of financials, Green Cross demonstrates superior responsiveness to changes in domestic and international economic conditions, as well as efficient profit generation capabilities compared to other stocks in the theme.

[Table] Top Financial Scores within the Theme


* The quant financial score is calculated by the robo-algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other financial indicators.

* This article was automatically generated in real time by a news automation algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist.

This content was produced with the assistance of AI translation services.